Charles Vincent Rajadurai

6PUBLICATIONS
28CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 26, 2026
Immunotherapy in Liver Transplant Recipients with Advanced Solid Malignancies: A Three-Patient Case Series.

|Jan 27, 2025
Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic Cancers.

Matthew Dankner, Emmanuelle Rousselle, Sarah Petrecca

|Nov 26, 2024
Evaluating the Efficacy of Immunotherapy in Fragile Hospitalized Patients.

Charles Vincent Rajadurai, Guillaume Gagnon, Catherine Allard

|May 26, 2023
An Unconventional Regimen of Carboplatin and Paclitaxel in Metastatic Colorectal Carcinosarcoma: A Case Report and Review of Literature.

Changsu Lawrence Park, Charles Vincent Rajadurai, Tuyet Nhung Ton Nu

|Oct 09, 2019
Arf6 regulates RhoB subcellular localization to control cancer cell invasion.

Kossay Zaoui, Charles V Rajadurai, Stéphanie Duhamel

|Sep 07, 2016
5'-Inositol phosphatase SHIP2 recruits Mena to stabilize invadopodia for cancer cell invasion.

Charles V Rajadurai, Serhiy Havrylov, Paula P Coelho

Pageof 1

Frequent Collaborators

2 joint publications

Morag Park

1 joint publications

Serhiy Havrylov

1 joint publications

Paula P Coelho

1 joint publications

Colin D H Ratcliffe